Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Sort by

    1. August 18, 2015 SBIR/ STTR FY16 Phase 1 Release 1 Topics Announced—Includes Hydrogen Production and Fuel Cell Membrane Topics The U.S. Department of Energy has announced the 2016 Small Business Innovation Research and Small Business Technology Transfer (SBIR/ STTR) Phase I Release 1 Topics, including hydrogen production from organic waste streams and fuel cell membranes, through the Office of ...

    2. ROCHESTER, N.Y., Aug. 20, 2015 /PRNewswire-USNewswire/ -- The U.S. Department of Energy (DOE) this week released its 2016 SBIR/STTR Phase I Release I Funding Opportunity Announcement (FOA). To view the FOA and corresponding deadlines, visit...

    3. Provata Health, the leader in evidence-based worksite wellness, received $1.4 million in Small Business Technology Transfer Phase II funding from the National Institutes of Health .

    4. Discover common resources available to and used by small business owners and entrepreneurs in funding initiatives through government grants.

    5. WALTHAM, Mass., Aug. 28, 2015 /PRNewswire/ -- Boston Engineering today announced a $150,000 contract from the U.S. Air Force to enhance its UAV capabilities and to also reduce drone noise. Specifically, ...

    6. TEL-AVIV, Israel -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, ...

    7. Internationally known leaders from key companies, funders and organizations, including Epic Semiconductors, Carabiner, University of California, Davis, Fred Hutchinson Cancer Research Center, Endeavour Partners, and WIRED magazine will present to an anticipated 300 participants in two weeks to share innovation best practices, emerging thought leadership in cannabis medical research, growing the...

    8. Press Release

      PharmiWebSep 01 06:12 AM

      TEL-AVIV, Israel, Sept. 1, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (TASE: RDHL ) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal (GI) diseases, including gastrointestinal cancers, today announced that the last patient ...

    9. TEL-AVIV, Israel -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, ...

    1. 12328 results